Live feed
Filing
SC 13D
SC 13D0000935836-20-000676·Logos Global Management LP
Schedule 13D ownership disclosure
Olema Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 60862P106
Event date: 2020-11-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,743,875
- Percent of class
- 9.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-20-000676
- Form type
- SC 13D
- Filer
- Logos Global Management LP
- CIK
- CIK 1792126
- Filed
- Dec 03, 2020
- Reporting period
- Nov 23, 2020
- Description
- Schedule 13D beneficial ownership